These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8894516)

  • 1. Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human.
    McLellan RA; Drobitch RK; Monshouwer M; Renton KW
    Drug Metab Dispos; 1996 Oct; 24(10):1134-8. PubMed ID: 8894516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norfloxacin interferes with cyclosporine disposition in pediatric patients undergoing renal transplantation.
    McLellan RA; Drobitch RK; McLellan H; Acott PD; Crocker JF; Renton KW
    Clin Pharmacol Ther; 1995 Sep; 58(3):322-7. PubMed ID: 7554706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M; Shindo M; Shimada T
    Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of several fluoroquinolones on hepatic microsomal cytochrome P-450 1A activities in dogs.
    Regmi NL; Abd El-Aty AM; Kuroha M; Nakamura M; Shimoda M
    J Vet Pharmacol Ther; 2005 Dec; 28(6):553-7. PubMed ID: 16343288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced inhibition of microsomal cytochrome P450 3A2 in rat liver during diltiazem biotransformation.
    Murray M; Butler AM
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1447-52. PubMed ID: 8968370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of ethyl carbamate by pulmonary cytochrome P450 and carboxylesterase isozymes: involvement of CYP2E1 and hydrolase A.
    Forkert PG; Lee RP
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):245-54. PubMed ID: 9344892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of theophylline and its inhibition by fluoroquinolones in rat hepatic microsomes.
    Davis JD; Aarons L; Houston JB
    Xenobiotica; 1995 Jun; 25(6):563-73. PubMed ID: 7483657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
    Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
    Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cytochrome P450 in oxazaphosphorine metabolism. Deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochromes P450.
    Yu L; Waxman DJ
    Drug Metab Dispos; 1996 Nov; 24(11):1254-62. PubMed ID: 8937861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitive effect of diphenytriazol on rat cytochrome P450 enzyme in vitro.
    Hu YZ; Yao TW
    Pharmazie; 2009 Jul; 64(7):455-60. PubMed ID: 19694183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue.
    Kuperman AV; Kalgutkar AS; Marfat A; Chambers RJ; Liston TE
    Drug Metab Dispos; 2001 Nov; 29(11):1403-9. PubMed ID: 11602515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide.
    Pekthong D; Martin H; Abadie C; Bonet A; Heyd B; Mantion G; Richert L
    J Ethnopharmacol; 2008 Feb; 115(3):432-40. PubMed ID: 18053665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
    Danie WA; Syrek M; Ryłko Z; Wójcikowski J
    Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
    Kasahara M; Suzuki H; Komiya I
    Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro metabolism of pyrethroid pesticides by rat and human hepatic microsomes and cytochrome p450 isoforms.
    Scollon EJ; Starr JM; Godin SJ; DeVito MJ; Hughes MF
    Drug Metab Dispos; 2009 Jan; 37(1):221-8. PubMed ID: 18948380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of fleroxacin on hepatic drug metabolism in the rat.
    Grech-Bélanger O; Francoeur J; Le Bel M
    Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):121-33. PubMed ID: 2501838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
    Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR
    Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of glyburide on human cytochrome p450 isoforms in human liver microsomes.
    Kim KA; Park JY
    Drug Metab Dispos; 2003 Sep; 31(9):1090-2. PubMed ID: 12920163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
    Usmani KA; Hodgson E; Rose RL
    Chem Biol Interact; 2004 Dec; 150(3):221-32. PubMed ID: 15560889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.